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Abstract 
Objectives: To evaluate changes in regional cerebral blood flow (rCBF) during wakeful rest in older 
subjects with mild to severe obstructive sleep apnea (OSA) and healthy controls, and to identify 
markers of OSA severity that predict altered rCBF.  
Design: High-resolution 99mTc-HMPAO SPECT images during wakeful rest.  
Setting: Research sleep laboratory affiliated with a University hospital. 
Participants: Fifty untreated OSA patients aged between 55 and 85 years divided into mild, moderate 
and severe OSA and 20 age-matched healthy controls.  
Interventions: N/A 
Measurements: Using statistical parametrical mapping, rCBF was compared between groups and 
correlated with clinical, respiratory and sleep variables. 
Results: Whereas no rCBF change was observed in mild and moderate groups, participants with severe 
OSA had reduced rCBF compared to controls in the left parietal lobules, precentral gyrus, bilateral 
postcentral gyri, and right precuneus. Reduced rCBF in these regions and in areas of the bilateral 
frontal and left temporal cortex was associated with more hypopneas, snoring, hypoxemia, and 
sleepiness. Higher apnea, micro-arousal, and body mass indexes were correlated to increased rCBF in 
the basal ganglia, insula, and limbic system.  
Conclusions: While older individuals with severe OSA had hypoperfusions in the sensorimotor and 
parietal areas, respiratory variables and subjective sleepiness were correlated with extended regions of 
hypoperfusion in the lateral cortex. Interestingly, OSA severity, sleep fragmentation and obesity 
correlated with increased perfusion in subcortical and medial cortical regions. Anomalies with such a 
distribution could result in cognitive deficits and reflect impaired vascular regulation, altered neuronal 
integrity, and/or undergoing neurodegenerative processes. 
Keywords: Obstructive sleep apnea, SPECT, regional cerebral blood flow, cerebral perfusion, 
neuroimaging, aging, snoring. 
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Abbreviations 
AHI; apnea-hypopnea index 
BA; brodmann area  
BMI; body mass index 
CBF; cerebral blood flow 
FDR; false discovery rate 
FWHM; full-width half-maximum  
MNI; Montreal Neurological Institute 
MRI; magnetic resonance imaging 
OSA; obstructive sleep apnea  
PET; positron emission tomography 
rCBF; regional cerebral blood flow 
SPECT; single-photon emission computed tomography 
SPM; statistical parametric mapping 




Obstructive sleep apnea (OSA) is a respiratory disorder characterized by repetitive pharyngeal 
collapses during sleep, causing snoring and transitory cessation (apneas) or reduction (hypopneas) of 
airflow amplitude, which result in intermittent hypoxemia.1,2 During these respiratory events, a 
profound increase in cerebral blood flow (CBF) is initially observed followed by an important decrease 
below resting values.3 Respiratory events generally end with a cortical arousal, which causes sleep 
fragmentation and further hemodynamic changes through an elevation of sympathetic tone.4 
Hypoxemia and nocturnal CBF fluctuations lead to cerebral hypoxia5 and neuronal, glial, and 
endothelial damage.6-8 Thus, altered cerebral perfusion, changes in vascular function, sleep 
fragmentation, and cellular damage may explain why OSA has been linked to excessive daytime 
sleepiness,1 cognitive deficits,9 and increases risks of cerebrovascular diseases.10-12  
So far, few neuroimaging studies have been performed in subjects with OSA during wakeful 
rest to estimate the impact of nocturnal respiratory events on brain function. Among them, studies 
using transcranial Doppler have shown that OSA individuals have impaired vascular regulation during 
wakefulness.3,13-15 Studies using magnetic resonance imaging (MRI) and emission tomography 
techniques have shown that OSA affects brain regions differently. In fact, one study using arterial spin 
labeling showed reduced regional CBF (rCBF) in several white matter tracts involved in the 
coordination of respiratory musculature, autonomic regulation and cognition.16 Furthermore, using 
single photon emission computed tomography (SPECT) or positron emission tomography (PET) 
combined to a statistical parametrical mapping (SPM) approach, four studies investigated cortical rCBF 
or glucose metabolism in untreated OSA individuals. All combined, these studies observed 
hypoperfusion or hypometabolism in the prefrontal cortex, the sensorimotor areas, the limbic system, 
the parietal lobes, the superior temporal cortex, and the anterior occipital cortex.17-20  
Nevertheless interesting, these studies show great inconsistencies regarding the cerebral regions 
affected in OSA, possibly due to methodological variability including the use of different apnea-
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hypopnea index (AHI) thresholds for OSA diagnosis (varied between 10 to 30 events/hours), different 
cardiovascular exclusion criteria, sample sizes (≤ 30 subjects in three of the four published SPECT and 
PET studies), and different statistical thresholds for neuroimaging results. In addition, most 
neuroimaging studies have focussed on middle-aged adults with severe OSA and therefore, older 
patients, especially those with mild or moderate OSA, are generally not investigated. Considering that 
the prevalence of OSA increases from 2-14% in the middle-aged adult population to 32-42% in 
individuals over 60 years of age,21 studying the impact of OSA in this age group is of utmost 
importance. In addition to presenting reduction in total CBF,22  findings from an animal study suggest 
that older individuals could be more vulnerable to intermittent hypoxia.23 which may lead to a more 
severe impact of OSA on brain function. Accordingly, brain perfusion changes during wakeful rest 
could be observed not only in severe OSA, but also in milder forms of OSA.  
The present study aimed at evaluating rCBF as a measure of brain function during wakeful rest 
using Technetium-99m Hexa-methyl-amino-propylenamine-oxime (99mTc-HMPAO) high-resolution 
SPECT in newly diagnosed and untreated mild, moderate and severe OSA patients aged from 55 to 85 
years and to compare them to controls without OSA. The novelty of the present study lies in the fact 
that a large sample was investigated to verify whether the pattern of reduced regional brain perfusion 
previously described in middle-aged OSA individuals would be observed in older subjects. This large 
sample size allowed us to divide our groups according to severity, which has not been done in previous 
studies. Another strength and novelty of this study was the high-resolution NeuroFOCUS SPECT 
scanner used, which provides 2.5 mm spatial resolution contrary to standard SPECT scanner (spatial 
resolution of 6-15 mm), enabling perfusion measurement in smaller regions. We hypothesized that 
OSA of mild or moderate severity in older subjects would be associated with reduced perfusion in 
cortical regions previously reported as abnormal in middle-aged OSA patients. More specifically, these 
hypoperfusions could be observed concomitantly in regions sensitive to hypoxemia (prefrontal cortex 
and hippocampus)24,25 and in regions showing relative hypoperfusion in normal aging (limbic system 
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and association cortex, especially frontal lobes).26 Another novelty of the present study is that we 
assessed the relationship between rCBF and several markers of OSA severity. We hypothesized that 
more severe levels of OSA (more respiratory events, lower oxygen saturation, and a more fragmented 
sleep), daytime sleepiness, and the presence of cardiovascular comorbidities as well as obesity would 
predict abnormal rCBF.  
2 Methods 
2.1 Sample 
Seventy subjects aged between 55 and 85 years (mean age: 64.5 ± 6.7; 15 females) were 
recruited from the pulmonary department of the Hôpital du Sacré-Coeur de Montréal and by ads in 
local newspapers. Participants with one or more of the following conditions were excluded: 1) central 
nervous system disorders (e.g. dementia, neurological diseases, traumatic brain injury, epilepsy); 2) 
uncontrolled diabetes or hypertension; 3) treatment with continuous positive airway pressure or other 
types of treatment such as a mandibular advancement device; 4) a body mass index (BMI) > 40 kg/m2; 
5) use of medication, drugs, or natural products known to influence cognition, cerebral functioning, 
sleep, and/or affect; and 6) a history of stroke (patients with a history of transient ischemic attacks were 
not excluded), sleep disorders other than OSA, or any major psychiatric disorders or pulmonary 
diseases. Written consent was obtained from each participant and the research protocol was approved 
by the ethics committee of the Hôpital du Sacré-Coeur de Montréal. 
2.2 Questionnaires  
Beck Depression Inventory-II27 and Beck Anxiety Inventory28 were used to document 
depression and anxiety symptoms. All participants were assessed for subjective daytime sleepiness 
using the Epworth Sleepiness Scale.29 Vascular risks factors and comorbidities were assessed using the 
Vascular Burden Index developed and validated by Villeneuve et al. (2009, 2011).30,31 This 
questionnaire screen for the presence of hypertension, hypotension, hypercholesterolemia/ 
dyslipidemia, coronary disease (angina pectoris, myocardial infarction, coronary artery bypass), 
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transitory ischemic attacks, diabetes, arrhythmias, and carotid stenosis, with a maximum total score of 
8 points. Presence of these risk factors was based on previous medical observations.  
2.3  Polysomnography recording 
All participants underwent a polysomnography recording that used measurements from thoraco-
abdominal strain gauges, an oronasal canula, and a transcutaneous finger pulse oximeter to measure 
oxygen saturation. Electroencephalographic sleep recordings were performed using an 18 
electroencephalogram channel montage accompanied by an electrooculogram, electromyograms on the 
chin and legs, and electrocardiogram. An apneic episode was defined as a total cessation of airflow 
lasting 10 s or more. A hypopneic episode was defined as a reduction in airflow of at least 30% from 
baseline lasting 10 s or more and accompanied by an oxygen desaturation of at least 3% or 
accompanied with an episode of arousal.32 The sum of apnea and hypopnea episodes divided by the 
number of hours of sleep provides the AHI. Sleep was recorded and scored by an experienced 
electrophysiology technician according to standard methods.33 For comparison purposes, based on 
published criteria,1 participants were categorized in three groups consisting of mild (AHI >5 and ≤15), 
moderate (AHI >15 and ≤30) and severe OSA (>30). Participants with an AHI ≤5 were considered as 
controls.  Polysomnographic results are shown in Table 1 for all groups.  
2.5       99mTc-HMPAO SPECT image acquisition 
All participants underwent a daytime 99mTc-HMPAO SPECT study during wakeful rest with a 
high-resolution brain-dedicated scanner (NeuroFOCUS, NeuroPhysics, Shirley, MA, USA) providing a 
2.5 mm full-width half-maximum (FWHM) spatial resolution. This resolution allows accurate 
evaluation of perfusion distribution in much smaller brain regions than with conventional 2- or 3-
headed gamma camera-based SPECT scanners. A dose of 750 MBq of 99mTc-HMPAO prepared in the 
morning of the testing was administered followed by a saline flush of 30 cc while the subject lied 
awake on a stretcher with their eyes closed. A static, 30-min acquisition was performed 20 minutes 
later. Thirty-two slices were reconstructed on a 128 x 128 matrix using a filtered back projection and an 
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attenuation correction was performed using Chang’s method with a coefficient of 0.01 cm-1. 
Reconstructed voxel size was 1.56 mm. This SPECT system does not allow for recording of the whole 
cerebellum in most subjects, and the cerebellar region was excluded from analysis. SPECT acquisitions 
were performed between 10:15 and 15:00 hours and were on average obtained 25.2 ± 23.1 days after 
the polysomnographic recording.   
2.6 Image analysis 
All SPECT images were evaluated visually for abnormalities. Using SPM8 (Statistical 
Parametric mapping 8, Wellcome Department of Imaging Neurosciences, Institute of Neurology, 
University College London, UK) with MatLab (version 7.3, The MathWorks, Natick, MA, USA), 
individual SPECT studies were registered and spatially normalized to the standard SPECT template 
included in the SPM8 software. Then, normalized images were smoothed using a 14-mm FWHM 
Gaussian filter. A proportional scaling normalization was used during analyses between images for 
their individual global mean signal. Thus, final regional results are relative to the mean global signal of 
CBF. Voxel size of the final images was 2.0 x 2.0 x 2.0 mm. 
2.7 Statistical analysis 
Descriptive statistics were performed for all study variables with STATISTICA 10.0 (Statsoft 
Inc., Tulsa, USA). Chi-square and t-tests were used with a statistical significance of p<0.05 to compare 
controls to OSA subjects in relation to their demographic, clinical, and polysomnographic variables. 
For the first research objective, group differences in rCBF distribution were assessed using SPM8 (two-
sample t-tests between healthy controls and each OSA group), corrected for multiple comparisons 
using false discovery rate (FDR)34 at p<0.05 with an extent threshold of 50 contiguous significant 
voxels across all grey matter, as previously described in Joo and al. (2007).17 In order to compare our 
results with other published imaging studies performed in subjects with OSA,18,19 a less stringent 
significance level with a height threshold of p<0.001 uncorrected was also used. However, we then 
increased the extent requirement to 200 contiguous significant voxels in order to reduce the false 
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positive rate. For the second objective, rCBF was correlated with all participants’ respiratory events 
(AHI, apnea index, hypopnea index), oxygen saturation (minimum, mean, total sleep time spent under 
90%), proportion of sleep time spent snoring, sleep efficiency, micro-arousal index, Epworth 
Sleepiness Score, BMI and vascular burden index. All correlations (multiple regression design) were 
done with age as a nuisance covariant and the same two statistical threshold mentioned before were 
used. The creation of a grey matter mask and the identification of significant regions (ICBM atlas) 
were performed with the software PickAtlas (version 3.0, ANSIR Laboratory, Wake Forest University 
School of Medicine, NC, USA). Resulting regions were superimposed on the SPECT template available 
in the SPM8 package. Figures were realized with the MRIcron software (Analyze viewer, Chris 
Rorden, PhD, Neuropsychology Lab, Columbia, SC, USA). 
3 Results 
3.1 Demographic, clinical and polysomnographic variables across groups 
Twenty-three subjects had mild OSA, 14 subjects had moderate OSA, and 13 subjects had 
severe OSA – for a total of 50 OSA subjects who were compared to 20 controls (see Table 1 for 
group’s demographic, clinical and polysomnographic characteristics and statistics). No differences in 
age, levels of subjective daytime sleepiness, depression, anxiety, vascular burden and sleep efficiency 
were found between groups.  
3.2 Group difference for rCBF  
Compared to controls, participants of the severe OSA group had decreased rCBF within a large 
cluster of voxels of the left hemisphere that includes the precentral and postcentral gyri and the superior 
and inferior parietal lobules (p<0.05 corrected with FDR, see Table 2 and Figure 1). Additional regions 
of hypoperfusion were found in severe OSA patients compared to controls using uncorrected threshold 
of p<0.001, namely the right postcentral gyrus and the right precuneus. Mild and moderate OSA groups 
showed no significant differences in rCBF with either statistical threshold when compared to controls. 
No regions of increased rCBF were found in OSA groups in comparison to healthy controls.  
 10 
3.3 Correlation analyses between rCBF and OSA-related variables 
In the correlational analysis including all subjects with or without OSA, several hypoperfusion 
foci were associated with increased disease severity (See Table 3 and Figure 2). Among the significant 
correlations observed, we found that higher AHI and higher hypopnea index were associated with 
hypoperfusions in the lateral portions of the left frontal (inferior and middle frontal gyri), sensorimotor 
(precentral and postcentral gyri), temporal (middle temporal gyrus) and parietal lobes (inferior parietal 
lobule) in addition to the right precuneus. A higher proportion of sleep spent snoring was associated 
with hypoperfusions in the left anterior parahippocampal gyrus, the anterior pole of the temporal lobe, 
as well as the inferior frontal gyrus. Hypoxemia, and more specifically the time spent with oxygen 
saturation below 90%, was correlated with reduced rCBF in the left dorsolateral prefrontal cortex, 
while subjective sleepiness measured by the Epworth Sleepiness Scale was associated with 
hypoperfused bilateral dorsomedial prefrontal cortex.  
OSA severity (higher AHI, apnea index and micro-arousal index) was also associated with 
hyperperfusions. Contrary to hypoperfusions (mostly in the lateral portion of the frontal, temporal and 
parietal cortex), hyperperfusions were all observed in the subcortical or medial cortical regions, 
including the caudate nucleus, the putamen, the amygdala, the hippocampus, the insula and the 
parahippocampal gyrus (see Table 4 and Figure 3), mostly in the right hemisphere. No correlation was 
found between rCBF and sleep efficiency.  
For cardiovascular comorbidities, no correlation was found between rCBF and the vascular 
burden index with either statistical threshold. However, higher BMI representing obesity was 
associated with both modest hypoperfusion in the postcentral gyrus and hyperperfusions in the 
hippocampi and the left parahippocampal gyrus extending to the globus pallidus (See Table 3 and 4, 
Figure 2 and 3).  
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4 Discussion 
In the present study, we investigated rCBF using a high-resolution SPECT scanner in a large 
sample of older subjects with mild, moderate and severe OSA during wakeful rest in order to evaluate 
brain function impairment in this population. Group comparisons showed that only severe OSA 
subjects had reduced rCBF in sensorimotor areas and parietal lobes, especially on the left side of the 
brain. Additionally, correlational analyses showed that higher levels of respiratory disturbances during 
sleep, greater daytime sleepiness, and obesity were associated to lateral cortical hypoperfusion of the 
parietal, temporal and frontal lobes. On the other hand, more respiratory events, fragmented sleep, and 
obesity were associated with hyperperfusion of subcortical and medial cortical structures, namely the 
basal ganglia, the limbic system, and the insula.  
4.1 Reduced rCBF in older subjects with severe OSA  
 The parietal hypoperfusion found in the present study could be a particularity of older OSA 
subjects. A recent SPECT study performed in 15 middle-aged subjects with severe OSA showed 
reduced rCBF only in the prefrontal areas.20 Another SPECT study investigating a relatively large 
sample of middle-aged men (27 controls and 27 severe OSA) found reduced rCBF in the 
parahippocampal and lingual gyri, but not in the parietal cortex.17 Even though SPECT studies in 
middle-aged OSA subjects failed to observed parietal hypoperfusion, two studies using PET in older 
middle-aged OSA subjects (54.8 ± 5.7 and 49.8 ± 7.0 years old respectively) reported reduced glucose 
metabolism in the parietal cortex.18,19 This either suggests that PET is more sensitive than SPECT in 
detecting parietal anomalies in middle-aged subjects or that changes in the parietal cortex tend to occur 
after the age of 50. Parietal hypoperfusion is a well-documented marker of early Alzheimer’s disease,35-
38 especially on the left side.39 Considering that OSA has been identified as a risk factor for mild 
cognitive impairment and dementia,40-42 a proportion of our severe OSA subjects may have underlying 
neurodegenerative processes. Indeed, hypoxia increases both the accumulation of amyloid-β and tau 
phosphorylation,43 which are pathological markers of Alzheimer’s disease. Additional longitudinal 
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cohort studies of OSA patients are definitely needed to understand how OSA contributes to abnormal 
cognitive decline in older subjects and whether parietal hypoperfusion is an early marker of subsequent 
dementia in OSA. 
Other mechanisms combined or not with the hypothetical neurodegenerative process may 
explain the regional cerebral hypoperfusion observed in older OSA individuals, namely a vascular 
dysfunction and/or a neuronal injury. First, during respiratory events, intermittent hypoxemia in 
combination with fast fluctuations in CBF and variations in blood pressure can lead to oxidative stress, 
inflammation, endothelial dysfunction, and atherosclerosis.8,43,44 Then, endothelial dysfunction and 
atherosclerosis directly reduce the diameter of blood vessels in addition to affect vasoreactivity, leading 
to hypoperfusion even during wakefulness.43,45 Concordant with this hypothesis, several studies have 
shown that OSA severity is associated with impaired cerebrovascular reactivity during wakefulness.13-
15,46,47 More specifically, subjects with OSA have reduced cerebrovascular autoregulation at rest, during 
hypoxia and hypercapnia, and during orthostatic hypotension.  
The second mechanism that could be responsible for decreased rCBF in OSA is neuronal 
injuries occurring as a consequence of nocturnal hypoxia, fluctuations in blood pressure and perfusion 
during respiratory events. Other processes secondary to respiratory events, including endothelial 
dysfunction, proteasomal activity, reactive gliosis, inflammation, reduced dendritic branching, impaired 
neurotransmitters production, and oxidative stress may also lead to neuronal function impairment 
and/or death.7,8,23,48,49 Since regional brain perfusion is closely correlated with local neuronal activity,50 
altered neuronal function following injuries or even loss could lead to hypoperfusion. Accordingly, 
several regions showing hypoperfusions in the present study were reported to have altered resting-state 
connectivity51-53 as well as cortical thinning or reduced grey matter density in middle-aged OSA 
individuals.18,54-56  
Although mechanisms underlying the vulnerability of some brain regions to vascular 
dysfunction or neuronal loss in the context of OSA are not fully understood, some characteristics of 
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these regions may explain their susceptibility. In fact, during hypoxia, cortical associative regions, 
which are phylogenically newer, are less protected in comparison to subcortical structures.57 Moreover, 
a study with severe OSA subjects using SPECT during sleep found reduced left parietal rCBF,58 which 
suggests an increased risk of vascular and neuronal impairment leading to daytime hypoperfusion. 
Finally, the inferior parietal lobe and the precuneus are part of the default mode network,59 as well as 
several regions found as impaired in association with OSA severity markers in our correlation analysis. 
It has been hypothesized that the default mode network could be particularly vulnerable to various 
injuries occurring in aging and in Alzheimer’s disease60 and this network has been shown to be 
impaired in previous functional MRI studies in OSA.52,61-63  
4.2 Normal rCBF in mild and moderate OSA 
Based on previous empirical evidence from an animal model of OSA in aging rats23 and on the 
reduction of global CBF with age,22 we expected that older subjects with mild and moderate OSA 
would show regional hypoperfusions, but our results did not confirm this hypothesis. The absence of 
brain anomalies among older subjects with mild OSA corroborates previous results in middle-aged 
patients, where a higher level of OSA severity was necessary to observe neuroimaging findings, 
namely silent lacunar infarctions and periventricular hyperintensities.64 as well as altered metabolite 
concentrations representing reduced neuronal integrity.65,66 Our results are also consistent with those 
found in neuropsychological studies of middle-aged and elderly subjects, which showed that cognitive 
deficits are more likely to be observed in individuals with moderate and severe OSA than in those with 
mild OSA or in healthy controls.67,68 These studies, combined with our results, suggest that a certain 
level of OSA severity, as measured with the AHI, is necessary to observe changes in brain function and 
metabolism, independently of age.  
4.3 Hypoperfusion and markers of OSA severity  
We found that OSA-related variables including hypopneas, proportion of time spent snoring, 
hypoxemia and subjective sleepiness were also associated with hypoperfusions in lateral portions of the 
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parietal, temporal and frontal lobes, especially in the left hemisphere. While hypopnea episodes were 
associated with reduced perfusion, apneas were not. Since apneas and hypopneas are characterized by 
different levels of hypoxemia, arousals and heart rate increases,69 further studies will be needed to 
understand the differential effect of cessations (apneas) and reductions (hypopneas) of airflow 
amplitude on brain perfusion and neuronal function. In addition to AHI and hypopnea index, snoring 
was also associated with reduced rCBF in the left anterior temporal pole extending to the frontal lobe. 
Habitual snoring in children without OSA increases the risk for cognitive problems and poorer 
academic performances,70 but the relation between brain function and snoring is not well understood in 
adults. It is possible that respiratory disturbances provoking snoring without reaching criteria to be 
considered apneas or hypopneas could affect the brain differently that apnea and hypopnea events. 
Although correlational analyses with markers of OSA severity are of particular importance in OSA 
studies, our group analyses leaded to two regions of hypoperfusion that were not observed in the 
correlational analyses (left parietal lobule, right postcentral gyrus), which could be caused by a non-
linear relationship between markers of OSA severity and rCBF.   
We also found that hypoxemia and sleepiness were associated with abnormal perfusion in the 
prefrontal cortex. Consistent with our findings, previous SPECT and PET studies, that investigated 
OSA subjects with higher levels of hypoxemia and subjective sleepiness than in our study, showed 
reduced prefrontal perfusion or metabolism,19,20 a region that seems particularly sensitive to hypoxemia 
and sleep deprivation.24 However, the prefrontal regions were not found to be altered in our group 
comparisons, suggesting that hypoxemia and subjective sleepiness should be considered as contributing 
factors to brain dysfunction independently of level of OSA severity as measured by the AHI in older 
individuals. 
4.4  Association between hyperperfusions and OSA-related variables  
Also of interest, significant higher rCBF in several subcortical areas (i.e. putamen, caudate 
nucleus, globus pallidus, amygdala and hippocampus) and medial cortical regions (i.e. insula and 
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parahippocampal gyrus) were associated with higher AHI, apnea and micro-arousal indexes. To our 
knowledge, hyperperfusions have not been previously reported in SPECT and PET studies in middle-
aged OSA subjects.17-20 However, a resting-state fMRI study in OSA reported increased connectivity in 
the basal ganglia and insula.53 These hyperperfusions may be specific to the older OSA population, but 
it is also possible that our large sample size used for the correlation analysis and the high spatial 
resolution of our SPECT scanner allowed the observation of small but significant changes in rCBF that 
were not previously found in emission tomography studies. In addition, hyperperfusions observed in 
the present study were not found in our group analysis, suggesting that increased rCBF is a more subtle 
change in brain functioning that occurs with increasing OSA severity and sleep fragmentation. This 
pattern of lateral cortical hypoperfusion and subcortical hyperperfusion may be explained by 
preferential protection of critical brain regions during apneic events and sleep deprivation. In fact, 
subcortical structures show marked increases in perfusion during hypoxia as compared to cortical 
regions,57 which may explain why subcortical regions could maintain higher perfusion values during 
wakefulness in subjects with OSA. On the other hand, some studies showed anatomical changes in 
subcortical structures in middle-aged OSA individuals,18,71-73 which could suggest neuronal injuries. 
Thus, despite altered structure, increased perfusion during hypoxia could partially protect those regions 
compared to lateral cortical regions, represented by a hyperperfusion and increased connectivity during 
wakeful rest.  
However, our analysis is scaled in function of the individual global signal of rCBF. It has been 
shown that OSA subjects have reduced mean CBF velocity,14 and we found reduction in rCBF in 
lateral cortical regions. This may result in reduced global rCBF, and in comparison, subcortical rCBF 
could be represented as hyperperfused with increased OSA severity, as it has been previously 
suggested in the aging population.74 Therefore, our hyperperfusion results may be a representation of 
either subcortical preservation of perfusion or compensatory increases in perfusion.  
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Although BMI was associated with a reduction in rCBF of the left parietal cortex, it was mostly 
correlated with increased perfusion in central structures including the hippocampus and 
parahippocampal gyrus, which were also increased in perfusion in association with the AHI, apneas 
and micro-arousals. The hippocampus and parahippocampal gyrus have been widely studied in the 
context of OSA and several studies showed reduced volume or density,18,54-56,71,72,75-77 changes in 
neuronal function assessed by fMRI51 and alteration in metabolites ratios.66,78,79 In animal studies, it 
was shown that apneas induce excitotoxicity in hippocampal neurons,25 that sleep fragmentation affects 
hippocampal synaptic plasticity,80 and that a diet with excess fat and refined carbohydrate enhances 
symptoms associated with hypoxic insult to the hippocampus.81 Thus, obesity could increase 
vulnerability to intermittent hypoxia and sleep fragmentation in OSA, and these alterations could be 
linked to increased daytime perfusion. Furthermore, early stage of Alzheimer’s disease may be 
characterized by hippocampus hyperactivity, thus suggesting again an underlying neurodegenerative 
process.82  
4.5 Impact of neuroimaging statistical thresholding 
In the current study, we used corrected and uncorrected statistical thresholds for neuroimaging 
analyses. It has been suggested that the vast differences in regions found in imaging studies on OSA 
could be attributed in part to the use of different statistical thresholds.83 Some variables were associated 
with rCBF changes only with the uncorrected threshold, such as the time spent with low oxygen 
saturation and BMI, which suggests that their effect could be less pronounced than other parameters. 
This is consistent with the fact that our subjects were not severely hypoxic nor morbidly obese. In 
addition, regions that were found to be significant with the less stringent statistical threshold were 
generally observed to be significantly affected by similar variables with the corrected threshold. 
Therefore, we suggest that the uncorrected threshold with a larger extent threshold could justifiably be 
used in the context of resting-state metabolic or perfusion tomography while the use of a corrected 
threshold could hide some modest changes in OSA, especially in studies with small sample sizes. 
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4.6 Limitations 
Some limitations in our study should be acknowledged. First, our scanning system did not allow 
for consistent evaluation of cerebellar perfusion changes. Although it has been often overlooked in 
OSA, the cerebellum seems to be vulnerable to intermittent hypoxia in an animal model84 and in 
humans.85 Thus, further studies should specifically investigate cerebellar function in OSA and its role 
in cognition in this population. Another limitation is that our OSA subjects were not severely hypoxic, 
with minimal oxygen saturation drops in the severe OSA group to an average of 82 ± 5.5%. It is 
possible that more hypoxic patients were not recruited in our study because they presented exclusion 
factors, such as a history of stroke or BMI > 40. Thirdly, our groups were not matched for sex. 
Although results concerning sex differences in regional brain perfusion are highly inconsistent,86 a 
study performed in older subjects showed that females have reduced rCBF in regions that were 
reported as hypoperfused in our study, including parietal areas.87 This suggests that our un-matched 
groups could have lead to increased risk of false negatives, since most of the females in our study were 
in the control group. Finally, the lack of relationship between vascular disease burden and regional 
perfusion could be due to the low number of concomitant comorbidities and risk factors in our subjects. 
Therefore, we could not eliminate the possibility that OSA and vascular risk factors interact to affect 
the brain.   
5 Conclusions 
Our results show that older individuals with newly diagnosed severe OSA show rCBF 
anomalies at rest, mostly in sensorimotor areas and the left parietal cortex. Considering that AHI is 
known to increase up to 53% in 17 months in older apneic patients without significant weight gain,88 
particular attention should be given to individuals with mild or moderate OSA in order to reduce their 
risk of eventually presenting brain/cognitive dysfunction linked to their condition. In addition, different 
variables representing OSA severity should be taken into account since they could independently 
contribute to abnormal brain and neuronal function. While most markers of respiratory disturbances, 
 18 
sleepiness, and obesity are associated with regional reductions of brain perfusion in lateral frontal, 
temporal and parietal areas, other factors such as respiratory events, sleep fragmentation, and obesity 
are associated with increased perfusion in subcortical and medial cortical areas including the limbic 
system, the insula and basal ganglia. These changes in regional perfusion could underlie vascular 
impairment and neuronal injuries, and be associated with deficits in several cognitive domains. The 
perfusion pattern observed in our study is similar to what is observed in early stage of Alzheimer’s 
disease, which suggests the presence of undergoing neurodegenerative processes. Indeed, 
hypoperfusion in Alzheimer’s disease is observed before clinical symptoms and is implicated in the 
progression of the disease.43 Thus, the role of OSA in neurodegeneration should be investigated as well 
as whether these functional changes are reversible or not with an appropriate treatment in future 
studies. 
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Figure 1. Location of the significant reductions in regional cerebral blood flow (rCBF) in severe 
obstructive sleep apnea (OSA) subjects compared with controls. A) Glass view of the significant 
clusters and B) overlays of significant regions on the SPECT template. Hypoperfusions were found in 
the left superior and inferior parietal lobules, the left precentral gyrus, bilateral postcentral gyri and 





Figure 2. Location of hypoperfusions that correlated with variables representing more severe 
obstructive sleep apnea (OSA). Regions showing hypoperfusions were as follow: A) and B) left 
inferior and middle frontal, precentral, postcentral, and middle temporal gyri, inferior parietal lobule, 
and right precuneus; C) left parahippocampal, anterior temporal pole, and inferior frontal gyri; D) left 
dorsolateral prefrontal cortex; E) bilateral dorsomedial prefrontal cortex; F) right postcentral gyrus. 




Figure 3. Locations of hyperperfusions that correlated with variables representing more severe 
obstructive sleep apnea (OSA). Regions showing hyperperfusions were as follow: A) right basal 
ganglia, amygdala, and hippocampus; B) right parahippocampal gyrus, insular cortex, and left 
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putamen; C) bilateral hippocampi, left parahippocampal gyrus, and globus pallidus. Results are 
overlays on the SPECT template and left side of images represent the left hemisphere of the brain.  
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Tables 












 n = 20 n = 23 n = 14 n = 13 AvsB AvsC AvsD 
Gender 8F; 12M 5F; 18M 1F; 13M 1F; 12M ns <0.05 <0.05 
Age (years) 64.1 (7.1) 64.5 (7.0) 63.9 (4.8) 65.8 (8.0) ns ns ns 
BMI (kg/m2) 25.6 (3.3) 27.3 (3.3) 28.1 (3.3) 27.6 (2.5) ns <0.05 ns 
Epworth Sleepiness 
Scale score 
9.0 (5.9) 7.0 (4.2) 11.5 (4.6) 9.2 (7.1) ns ns ns 
Beck Depression 
Inventory score 
5.9 (5.2) 6.7 (6.0) 8.7 (5.2) 6.8 (5.4) ns ns ns 
Beck Anxiety Inventory 
score 
4.8 (4.8) 3.7 (4.2) 6.0 (6.4) 5.0 (4.5) ns ns ns 
Vascular burden index 0.9 (1.0) 1.5 (1.3) 1.1 (1.0) 1.6 (1.6) ns ns ns 
Subjects with vascular 
burden > 2/8 (%) 
20 52 43 39 ns ns ns 
Polysomnographic variables      
AHI (events/h) 2.8 (2.0) 10.1 (2.7) 23.0 (4.3) 40.9 (11.1) <0.001 <0.001 <0.001 
Apnea Index (events/h) 0.7 (1.1) 3.3 (3.0) 10.7 (6.0) 26.9 (11.7) <0.001 <0.001 <0.001 
Hyponea Index    
(events/h) 
2.1 (1.7) 6.8 (2.8) 12.3 (5.6) 14.1 (5.9) <0.001 <0.001 <0.001 
Minimal SpO2 (%) 89.5 (2.9) 87.8 (5.3) 82.4 (6.0) 82.0 (5.5) ns <0.001 <0.001 
Mean SpO2 (%) 94.9 (0.9) 95.4 (1.2) 94.2 (0.8) 94.5 (0.6) ns <0.05 ns 
TST with SpO2<90% 
(min) 
0.5 (1.0) 1.0 (1.5) 6.5 (5.7) 15.4 (19.1) ns <0.001 <0.001 
Snoring (% of TST) 8.6 (14.5) 14.5 (15.5) 34.4 (24.4) 15.5 (12.9) ns <0.001 ns 
Micro-arousal index 
(number/h) 
11.4 (3.7) 11.9 (4.6) 15.8 (7.5) 21.6 (6.9) ns <0.05 <0.001 
Sleep efficiency (%) 78.9 (12.4) 77.5 (13.1) 78.6 (12.7) 76.1 (11.3) ns ns ns 
Results are presented as mean (standard deviation). OSA, obstructive sleep apnea; F, females; M, males; ns, non 








    
MNI 
coordinates 
Location p Side BA 
Peak t-
values 




L 2 4.54 -55 -28 54 
Superior parietal lobule L 7 4.20 -30 -60 67 
Precentral gyrus L 4,6 4.19 -41 -16 68 
Inferior parietal lobule  
(angular gyrus) 
L 40 4.07 -58 -50 46 
244 Postcentral gyrus 0.001 uncorrected R 2 5.54 14 -50 78 
274 Precuneus 0.001 uncorrected R 7 4.67 7 -78 52 
236 
Inferior parietal lobule 
(supramarginal gyrus) 0.001 uncorrected 
L 40 3.77 -67 -32 32 
Postcentral gyrus L 3 3.63 -68 -16 29 










    MNI coordinates 
Location p Side BA 
Peak t-
values 
x y z 




L 3 4.41 -58 -38 50 
Precentral gyrus L 6 3.64 -64 -16 44 
Inferior parietal lobule  
(angular gyrus) 
L 40 3.56 -56 -42 52 
288 Precuneus 0.001 uncorrected R 7 4.85 7 -78 52 
212 Inferior frontal gyrus 0.001 uncorrected L 47 4.62 -54 30 0 
Hypopnea Index       
683 
Inferior parietal lobule 
(supramarginal gyrus) 
0.05 corrected 
L 40 4.44 -70 -28 26 
Middle temporal gyrus L 21 3.86 -67 -6 -6 
Postcentral gyrus L 40 3.69 -58 -28 54 
389 Inferior frontal gyrus 0.001 uncorrected L 47 4.31 -56 28 -2 
340 Middle frontal gyrus 0.001 uncorrected L 6 4.09 -58 6 46 




L 34 4.86 -14 -4 -26 
Medial temporal pole L 38 4.83 -34 16 -32 
Lateral temporal pole L 38 4.22 -54 14 -26 
 Inferior frontal gyrus  L 45 3.61 -56 34 4 
Time spent with oxygen saturation <90%       
297 Superior frontal gyrus 0.001 uncorrected L 8 4.82 -16 28 54 
219 Middle frontal gyrus 0.001 uncorrected L 9 4.41 -48 28 36 
Epworth Sleepiness Scale       
580 
Superior medial frontal gyrus 
0.05 corrected 
L 9 4.25 -8 48 40 
Superior medial frontal gyrus L 8 3.85 -6 34 44 
Superior medial frontal gyrus R 8 3.76 4 20 50 
Body mass index       
218 Postcentral gyrus 0.001 uncorrected R 2 4.44 64 -18 28 










   MNI coordinates 
Location p Side 
Peak t-
values 
x y z 




R 4.45 30 -6 -16 
Caudate nucleus, Putamen R 3.83 10 10 -4 




R 4.53 30 -6 -16 
Caudate nucleus, Putamen R 3.88 10 8 -2 




R 4.38 26 2 -14 
Insula R 3.73 32 18 -6 
249 Putamen 0.001 uncorrected L 3.99 -28 2 -6 




L 3.82 -26 -20 -12 
Parahippocampal gyrus L 3.61 -18 -25 -16 
Globus pallidus (lentiform nucleus) L 3.46 -18 -9 5 
208 Hippocampus 0.001 uncorrected R 3.82 32 -14 -16 
MNI, Montreal Neurological Institute; L, left; R, right 
 
 
 
 
 
 
 
